Loading clinical trials...
Loading clinical trials...
An Open Label, Non-interventional Study Of The Safety Of Desvenlafaxine Succinate (Pristiq) In The Treatment Of Major Depressive Disorder (Mdd) And Vasomotor Symptoms (Vms) Associated With Menopause In Filipino Adult Patients: A Post Marketing Surveillance Study
Conditions
Interventions
desvenlafaxine succinate
Locations
3
Philippines
Private Clinic
Las Piñas, Philippines
Private Clinic
Manila, Philippines
Private Clinic
Pasay, Philippines
Start Date
March 1, 2012
Primary Completion Date
August 1, 2012
Completion Date
August 1, 2012
Last Updated
January 18, 2016
NCT07115329
NCT06793397
NCT07025720
NCT06780917
NCT04480918
NCT07422519
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions